Latest

ambroxol

·July 1, 2025·5 min read

Cough Medicine Shows Promise in Slowing Parkinson’s Dementia

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia. The 12-month study found that the drug stabilized psychiatric symptoms, protected against brain damage, and even improved cognition in genetically at-risk participants.

Featured Neurology Neuroscience

·January 11, 2023·3 min read

Cough Medicine Could Be Used in New Treatment for Parkinson’s Disease

Ambroxol, a common medicine used to treat respiratory illnesses shows promise as a treatment to slow the progression of Parkinson's disease. Researchers report ambroxol increases the level of GCase, a protein that allows cells to remove waste proteins including alpha synuclein.

Featured Neurology Neuroscience Open Neuroscience Articles

·February 16, 2020·4 min read

Cough syrup drug being trialed as Parkinson’s treatment

Ambroxol, a medication approved to treat coughs, may slow the progression of Parkinson's disease. The medication is able to effectively cross the blood-brain barrier and increases levels of GCase in patients' brains. Ambroxol also appears to reduce Parkinson's-related alpha-synuclein levels.